CAS No. 171596-29-5: Tadalafil — A Scientific and Pharmaceutical Overview

CAS No. 171596-29-5: Tadalafil — A Scientific and Pharmaceutical Overview

Tadalafil, identified by CAS No. 171596-29-5, is a well-known pharmaceutical compound widely studied for its therapeutic applications and pharmacological properties. It belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors and has gained significant importance in modern medicine due to its effectiveness in treating specific vascular-related conditions.

Introduction to Tadalafil

Chemically, tadalafil is a complex organic molecule with the molecular formula C₂₂H₁₉N₃O₄ and a molecular weight of approximately 389.4 g/mol. It is typically found as a white to off-white crystalline powder with limited solubility in water but good solubility in organic solvents like DMSO. The compound is structurally unique 

compared to other PDE5 inhibitors, featuring a β-carboline core. This distinct structure contributes to its pharmacological behavior, particularly its long duration of action.

Mechanism of Action

Tadalafil functions primarily by inhibiting the enzyme phosphodiesterase type 5 (PDE5). This enzyme is responsible for breaking down cyclic guanosine monophosphate (cGMP), a molecule that regulates smooth muscle relaxation in blood vessels.

By inhibiting PDE5, tadalafil increases cGMP levels, resulting in:

  • Relaxation of smooth muscle cells

  • Vasodilation (widening of blood vessels)

  • Enhanced blood flow in specific tissues

This mechanism is particularly important in areas such as the corpus cavernosum, where increased blood flow facilitates physiological responses required for certain medical conditions.

Pharmacokinetics and Duration

One of the most distinguishing features of tadalafil is its long half-life of approximately 17.5 hours, which allows it to remain active in the body for an extended period.

Unlike some similar compounds, tadalafil can maintain therapeutic effects for up to 36–48 hours, offering a broader window of activity. This extended duration reduces the need for precise timing in administration and contributes to its popularity in clinical settings.

Absorption occurs relatively quickly, with peak plasma concentrations typically reached within about 2 hours after oral administration. The compound is metabolized primarily in the liver via the cytochrome P450 enzyme system (CYP3A4) and is excreted mainly through feces and urine. 

Therapeutic Applications

Tadalafil has been widely studied and utilized for several medical conditions, including:

  1. Erectile Dysfunction (ED)
    Tadalafil improves blood flow to specific tissues, enabling improved physiological function in individuals experiencing erectile dysfunction.

  2. Benign Prostatic Hyperplasia (BPH)
    It helps relieve urinary symptoms associated with prostate enlargement by relaxing smooth muscles in the bladder and prostate.

  3. Pulmonary Arterial Hypertension (PAH)
    The drug aids in reducing pulmonary blood pressure by relaxing blood vessels in the lungs, thereby improving exercise capacity and overall cardiovascular function.

These applications highlight the compound’s role as a vascular modulator, extending beyond a single therapeutic use.

Chemical and Physical Properties

Tadalafil exhibits several notable chemical and physical characteristics:

  • Appearance: White to beige crystalline solid

  • Melting Point: Approximately 298–300°C

  • Density: Around 1.5 g/cm³

  • Solubility: Soluble in organic solvents, limited aqueous solubility

It is typically stored under controlled conditions (2–8°C or lower) to maintain stability, as it may degrade under certain environmental conditions.

Safety and Side Effects

Like any pharmacologically active compound, tadalafil may produce side effects. The most commonly reported include:

  • Headache

  • Back pain

  • Indigestion (dyspepsia)

  • Muscle aches

In rare cases, prolonged physiological effects may occur, requiring medical attention. Additionally, tadalafil should not be used in combination with certain medications, particularly nitrates, due to the risk of significant drops in blood pressure.

Advantages Over Similar Compounds

Tadalafil offers several advantages compared to other PDE5 inhibitors:

  • Longer duration of action, allowing greater flexibility

  • Food-independent absorption, meaning it can be taken with or without meals

  • Sustained efficacy, reducing dosing frequency

These features make it a preferred option in many clinical scenarios.

Research and Broader Implications

Beyond its established uses, tadalafil continues to be explored in research settings for its effects on endothelial function and cardiovascular health. Its ability to enhance blood flow and improve vascular function suggests potential applications in broader therapeutic areas.

Additionally, studies indicate that tadalafil may contribute to improved endothelial health, particularly in patients with cardiovascular risk factors. 

Conclusion

Tadalafil (CAS No. 171596-29-5) is a significant compound in modern pharmacology, known for its potent and selective inhibition of PDE5. Its unique chemical structure, long duration of action, and versatile therapeutic applications make it an important subject of both clinical use and ongoing research.

From treating vascular-related conditions to improving quality of life in patients, tadalafil demonstrates how targeted molecular design can lead to impactful medical advancements. As research continues, its full potential in various therapeutic domains may become even more apparent.

Other recommended Link: CAS NO 79559-97-0 (SERTRALINE HYDROCHLORIDE)